MINNEAPOLIS - February 14, 2014 - Medtronic, Inc. (MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial, which found that continuous ...
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in ...
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results